The comparative safety of abciximab versus eptifibatide in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
Devraj Sukul; Milan Seth; Theodore Schreiber; George Hanzel; Akshay Khandelwal; Louis A. Cannon; Thomas A. Lalonde; Hitinder S. Gurm
Author Information: Department of Internal Medicine
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.